Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Beard

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Structure and activity of botulinum neurotoxin XMarkel Martínez-Carranza, Jana Škerlová, Pyung-Gang Lee, et al.
Nature Communications|July 5, 2017
Engineered botulinum neurotoxin B with improved efficacy for targeting human receptorsLiang Tao, Lisheng Peng, Ronnie P-A Berntsson, et al.
Pharmacology Research & Perspectives|October 11, 2021
Recombinant botulinum neurotoxin serotype A1 in vivo characterizationCindy Périer, Vincent Martin, Sylvie Cornet, et al.
Communications Chemistry|August 13, 2024
Activity of botulinum neurotoxin X and its structure when shielded by a non-toxic non-hemagglutinin proteinMarkel Martínez-Carranza, Jana Škerlová, Pyung-Gang Lee, et al.
Science Advances|February 13, 2019
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical modelsMark Elliott, Christine Favre-Guilmard, Sai Man Liu, et al.
The New Zealand Medical Journal|December 24, 2013
Exposure to harmful housing conditions is common in children admitted to Wellington HospitalAshton Kelly, Georgina Denning-Kemp, Karl Geiringer, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Structure and activity of botulinum neurotoxin XMarkel Martínez-Carranza, Jana Škerlová, Pyung-Gang Lee, et al.
Nature Communications|July 5, 2017
Engineered botulinum neurotoxin B with improved efficacy for targeting human receptorsLiang Tao, Lisheng Peng, Ronnie P-A Berntsson, et al.
Pharmacology Research & Perspectives|October 11, 2021
Recombinant botulinum neurotoxin serotype A1 in vivo characterizationCindy Périer, Vincent Martin, Sylvie Cornet, et al.
Communications Chemistry|August 13, 2024
Activity of botulinum neurotoxin X and its structure when shielded by a non-toxic non-hemagglutinin proteinMarkel Martínez-Carranza, Jana Škerlová, Pyung-Gang Lee, et al.
Science Advances|February 13, 2019
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical modelsMark Elliott, Christine Favre-Guilmard, Sai Man Liu, et al.
The New Zealand Medical Journal|December 24, 2013
Exposure to harmful housing conditions is common in children admitted to Wellington HospitalAshton Kelly, Georgina Denning-Kemp, Karl Geiringer, et al.
Pageof 4